MARLENE ANDERSON-REID: Open Payments
NPI 1396089181 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 11 companies in 2025. Trend: 2023 $538 · 2024 $446 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Travere Therapeutics, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| KYOWA KIRIN, INC. | 1 | $19 |
Products named: Fabhalta, Kerendia, FARXIGA, JARDIANCE, JYNARQUE, Empaveli, TARPEYO, INJECTAFER.
Industry payments across GA — which companies pay providers there.
